Experimental Immune Therapy Tested in Preliminary Study of Women with Triple-Negative Breast Cancer - 4/20/15

Early data in a preliminary human study show that an experimental immune system drug is generally safe and well tolerated in women with metastatic, triple-negative breast cancer, a persistently difficult form of the disease to treat.
Source: Johns Hopkins Medicine News - Category: Research Source Type: news